Diasorin Ltd
COMPANY INFORMATION
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide range of clinical areas. DiaSorin tests are designed for hospital and private testing laboratories, in the markets of immunodiagnostics and molecular diagnostics.
LATEST STORIES
PRODUCTS AND SERVICES
Latest Issues
Launch Diagnostics provides complete pathology solutions with a comprehensive portfolio of high-quality diagnostic reagents and instrumentation from world leading manufacturers to the Health Services of the United Kingdom. Our associated companies also provide solutions to France, Belgium, and Luxemburg through Launch Diagnostics SAS and to the...
UK NEQAS webinar: IHC Technical Issues and Quality Assurance
Online
13-15 October, 2026
Lab Innovations
NEC, Birmingham
4-5 November, 2026
UK NEQAS webinar: IHC Applications in Laboratory Practice
Online
10-12 November, 2026
BAC Annual Scientific Meeting
Newcastle upon Tyne
13 November, 2026
DIA-MHRA Global Summit
Senate House, Malet Street, London, WC1E 7HU
16-17 November, 2026